Skip Navigation



Annals of Oncology Advance Access published online on October 24, 2007
Annals of Oncology, doi:10.1093/annonc/mdm350
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
19/3/433    most recent
mdm350v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Boersma, R. S.
Right arrow Articles by Schouten, H. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Boersma, R. S.
Right arrow Articles by Schouten, H. C.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2007 European Society for Medical Oncology

review

Thrombotic and infectious complications of central venous catheters in patients with hematological malignancies

R. S. Boersma1,*, K.-S. G. Jie1, A. Verbon2, E. C. M. van Pampus3 and H. C. Schouten3

1 Atrium Medical Centre Heerlen, Department of Internal Medicine, Heerlen
2 University Hospital Maastricht, Department of Medical Microbiology and Department of Internal Medicine, Division of General Internal Medicine, Section Infectious Diseases, Heerlen
3 University hospital Maastricht, Department of Internal Medicine, Division of Haematology, Heerlen, The Netherlands

* Correspondence to: Dr R. S. Boersma, University Hospital Maastricht, Department of Internal Medicine, Postbus 5800, 6202 AZ Maastricht, The Netherlands. Tel: +31-43-3877005; Fax: +31-43-3875006; E-mail: rinskeboersma{at}hotmail.com

Central venous catheters (CVCs) have considerably improved the management of patients with hematological malignancies, by facilitating chemotherapy, supportive therapy and blood sampling. Complications of insertion of CVCs include mechanical (arterial puncture, pneumothorax), thrombotic and infectious complications. CVC-related thrombosis and infections are frequently occurring complications and may cause significant morbidity in patients with hematological malignancies. CVC-related thrombosis and infections are related and can therefore not be seen as separate entities. The incidence of symptomatic CVC-related thrombosis had been reported to vary between 1.2 and 13.0% of patients with hematological malignancy. The incidence of CVC-related bloodstream infections varies between 0.0 and 20.8%. There is need for a specific approach regarding diagnosis and treatment of CVC-related thrombosis and infection with specific attention to the preservation of the catheter. Since data on CVC-related infections and thrombosis in hematological patients have been obtained mainly from retrospective studies of small sample size, prospective, randomized studies of prophylactic measures concerning CVC-related thrombosis and infection are warranted.

central venous catheter-related infections, central venous catheter-related thrombosis, hematological malignancies

Received for publication February 22, 2007. Revision received June 6, 2007. Accepted for publication June 8, 2007.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.